Abstract:Objective. To explore the expression of the polymorphism and mutation of rs682429 and rs3781590 in the low-density lipoprotein receptor-related protein 5 (LRP5) genotype and to analyse the relationship of bone mineral density (BMD) and bone metabolism markers in postmenopausal women with type-2 diabetes mellitus (T2DM) in Xinjiang, China, to provide a basis for prevention and treatment of the disease. Methods. A total of 136 postmenopausal women were included in the study. According to the results of an oral glucose tolerance test (OGTT) and dual-energy X-ray (DEXA) determination of BMD, the study subjects were divided into 4 groups: group A: normal OGTT+normal bone mass group; group B: normal OGTT+osteoporotic (OP) group; group C: T2DM+normal bone mass group; group D: T2DM+osteoporotic (OP) group. Calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), and clinical biochemical data were determined; haemoglobin A1c (HbA1c) was measured by HPLC; BMD of the femoral neck, hip, and lumbar spine (L1-4) was measured by dual-energy X-ray (DEXA); and the rs682429 and rs3781590 polymorphisms of the LRP5 gene were detected by time-of-flight mass spectrometry (TOF MS). Results. (1) The rs682429 polymorphism of the LRP5 genotype distribution was statistically significant ( P < 0.05 ) in group B compared with group A. (2) The triglycerides (TG) of women with the CT/TT genotype (mutant type) were higher than those of women with the CC genotype (wild type) ( 2.37 ± 1.30 vs. 1.52 ± 0.83 , P < 0.05 ) at the rs3781590 site of the LRP5 gene in group D. (3) Multiple linear regression analysis showed that TG ( β = 0.034 , P < 0.05 ) and body mass index (BMI) ( β = 0.013 , P < 0.05 ) were the influencing factors of BMD (L1-4) in T2DM patients. TG ( β = 0.022 , P < 0.05 ), BMI ( β = 0.009 , P < 0.05 ), and duration of menopause ( β = 0.005 , P < 0.05 ) were the influencing factors of BMD (hip). Conclusion. (1) The rs682429 polymorphism site in the LRP5 gene may be involved in bone metabolism in postmenopausal women from Xinjiang. (2) The rs3781590 mutation in the LRP5 gene from these subjects may be involved in lipid metabolism. (3) Among postmenopausal women with type 2 diabetes mellitus and bone mass abnormality in the Xinjiang Shihezi area, high BMI and TG are protective factors against increased BMD. Duration of menopause is a risk factor for increased BMD.

Association between T950C and A163G polymorphism of the osteoprotegerin gene and bone mineral density in elderly type 2 diabetic patients

Association between T245G polymorphisms in the osteoprotegerin gene and bone mineral density in elderly individuals

Association between A163G polymorphism of the osteoprotegerin gene and bone mineral density in the Chinese elderly from Beijing Area

Association of the G.27563g>a Osteoprotegerin Genetic Polymorphism with Bone Mineral Density in Chinese Women.

Association of LRP5 gene polymorphism with osteoporosis in postmenopausal type 2 diabetic women

Association Of Lrp5 Gene Polymorphism With Type 2 Diabetes Mellitus And Osteoporosis In Postmenopausal Women

A Study of the Relationship between the Polymorphism and Mutation of rs682429 and rs3781590 in the LRP5 Gene and Bone Metabolism in Postmenopausal Type 2 Diabetic Women in Xinjiang

[Effect of Osteoprotegerin Gene Polymorphism on Bone Mass in Postmenopausal Women].

The Study of the Association Between T950C Gene Polymorphism in the Promoter Region of Osteoprotegerin and Bone Mineral Density in Postmenopausal Women

SAA1 Gene Polymorphisms in Osteoporosis Patients

Relationship Between the Gene Polymorphism of Osteoprotegerin and Bone Mineral Density in Hemodialysis Patients.

[Osteoprotegerin Gene Polymorphism and Therapeutic Response to Alendronate in Postmenopausal Women with Osteoporosis].

Clinical Multivariate Analysis of Osteoporosis in Elderly Patients with Type 2 Diabetes

Bone mineral density and its related factors in elderly male Chinese patients with type 2 diabetes.

EFFECT OF OSTEOPROTEGERIN GENE POLYMORPHISM ON BONE MASS IN PREMENARCHE GIRLS

Investigation of the correlative factors for osteoporosis among elderly male patients with type 2 diabetes

Association of G209A and T245G polymorphisms of osteoprotegerin gene promoter with bone mineral density and bone turnover in females

Association Between Hemoglobin Levels and Osteoporosis in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Elevations of N-Terminal Mid-Fragment of Osteocalcin and Cystatin C Levels are Associated with Disorders of Glycolipid Metabolism and Abnormal Bone Metabolism in Patients with Type 2 Diabetes Mellitus Complicated with Osteoporosis

The Relationship Between Insulin Resistance and Osteoporosis in Elderly Male Type 2 Diabetes Mellitus and Diabetic Nephropathy

Based on HbA1c Analysis: Bone Mineral Density and Osteoporosis Risk in Postmenopausal Female with T2DM.